Market Risers: RSA Insurance Group plc, AstraZeneca plc, Admiral Group plc, Direct Line Insurance Group PLC, Legal & General Group Plc & Burberry Group plc

RSA Insurance Group
[shareaholic app="share_buttons" id_name="post_below_content"]

The trading price for RSA Insurance Group plc EPIC code: LON:RSA has climbed 1.16% or 6.2 points throughout today’s trading session so far. Market buyers seem confident throughout the session. The periods high has already touched 542.8 meanwhile the session low reached 537.2. The amount of shares exchanged has so far reached 375,467 with the average number of shares traded daily being 5,464,791. The 52 week high for the share price is 683.4 which is 147.4 points difference from the previous close and the 52 week low at 531 making a difference of 5 points. RSA Insurance Group plc now has a 20 simple moving average of 556.44 and a 50 day moving average now of 591.43. This puts the market capitalisation now at £5,546.90m at the time of this report. The stock is traded in GBX. Mcap is measured in GBP. This article was written with the last trade for RSA Insurance Group plc being recorded at Thursday, November 8, 2018 at 12:04:56 PM GMT with the stock price trading at 542.2 GBX.

 

Shares of AstraZeneca plc EPIC code: LON:AZN has increased 1.52% or 89 points during today’s session so far. Market buyers seem confident during this period. The high for the period has reached 5997 dropping as low as 5901. The volume total for shares traded up to this point was 645,174 with the daily average at 2,438,184. A 52 week high for the stock is 6126.4 some 269.4 points different to the previous business close and a 52 week low sitting at 4544.5 which is a variance of 1312.5 points. AstraZeneca plc has a 20 SMA of 5887.53 and now a 50 day SMA of 5846.51. Market capitalisation is now £73,693.92m at the time of this report. The share price is in Great British pence. Mcap is measured in GBP. This article was written with the last trade for AstraZeneca plc being recorded at Thursday, November 8, 2018 at 12:04:43 PM GMT with the stock price trading at 5946 GBX.

 

The trading price for Admiral Group plc EPIC code: LON:ADM has stepped up 1.33% or 26.5 points throughout today’s trading session so far. Investors have remained positive during the trading session. The period high has peaked at 2013 and hitting a low of 1993. The number of shares traded by this point in time totalled 50,912 with the daily average traded share volume around 890,824. The 52 week high for the shares is 2138 about 151.5 points difference from the previous days close and putting the 52 week low at 1794.5 which is a variance of 192 points. Admiral Group plc now has a 20 SMA at 1996.11 and also a 50 day simple moving average now of 2036.06. The current market cap is £5,815.62m at the time of this report. Share price is traded in GBX. Mcap is measured in GBP. This article was written with the last trade for Admiral Group plc being recorded at Thursday, November 8, 2018 at 12:04:26 PM GMT with the stock price trading at 2013 GBX.

 

The share price for Direct Line Insurance Group PLC with company EPIC: LON:DLG has climbed 1.13% or 3.6 points throughout today’s trading session so far. Market buyers seem confident throughout the trading session. Range high for the period has seen 322.5 and hitting a low of 318.5. The total volume traded so far comes to 514,271 while the daily average number of shares exchanged is 5,892,663. A 52 week high for the stock is 397 some 78.4 points in difference on the previous days close and a 52 week low being 307.8 a difference of some 10.8 points. Direct Line Insurance Group PLC now has a 20 moving average of 327.44 and now a 50 day moving average of 328.42. The market capitalisation currently stands at £4,420.54m at the time of this report. All share prices mentioned for this stock are traded in GBX. Mcap is measured in GBP. This article was written with the last trade for Direct Line Insurance Group PLC being recorded at Thursday, November 8, 2018 at 12:03:58 PM GMT with the stock price trading at 322.2 GBX.

 

The share price for Legal & General Group Plc ticker lookup code: LON:LGEN has climbed 1.01% or 2.6 points during today’s session so far. Traders have remained positive throughout the trading session. Range high for the period has seen 260.1 and a low of 257.1. The amount of shares exchanged has so far reached 2,586,337 with the average number of shares traded daily being 21,667,522. The 52 week high for the share price is 289.45 amounting to 32.45 points different to the previous business close and a 52 week low sitting at 236 making a difference of 21 points. Legal & General Group Plc has a 20 day moving average of 249.08 and now its 50 day MA at 255.14. Market capitalisation for the company is £15,366.05m at the time of this report. All share prices mentioned for this stock are traded in GBX. Mcap is measured in GBP. This article was written with the last trade for Legal & General Group Plc being recorded at Thursday, November 8, 2018 at 12:05:01 PM GMT with the stock price trading at 259.6 GBX.

 

Shares of Burberry Group plc ticker code: LON:BRBY has risen 1.79% or 32.5 points during today’s session so far. Market buyers have stayed positive throughout the session. The periods high has already touched 1859 while the low for the session was 1815.5. The total volume of shares exchanged so far has reached 558,624 with the daily average traded share volume around 2,822,591. A 52 week high for the stock is 2338 amounting to 522 points in difference to the previous days close of business and a 52 week low sitting at 1481.5 a difference of some 334.5 points. Burberry Group plc now has a 20 moving average of 1778.66 and a 50 day simple moving average now at 1968.07. The current market cap is £7,547.98m at the time of this report. The stock is traded in GBX. Mcap is measured in GBP. This article was written with the last trade for Burberry Group plc being recorded at Thursday, November 8, 2018 at 12:04:40 PM GMT with the stock price trading at 1848.5 GBX.

Twitter
LinkedIn
Facebook
Email
Reddit
Telegram
WhatsApp
Pocket
Find more news, interviews, share price & company profile here for:
    AstraZeneca's Imfinzi receives FDA approval for limited-stage small cell lung cancer, marking a significant breakthrough in extending patient survival.

      Search

      Search